Globe Life (GL) to Release Quarterly Earnings on Wednesday

Globe Life (NYSE:GL) will likely be announcing its earnings results after the market closes on Wednesday, February 5th. Analysts expect the company to announce earnings of $3.12 per share and revenue of $1.48 billion for the quarter. Persons interested in listening to the company’s earnings conference call can do so using this link.

Globe Life Price Performance

GL stock opened at $122.17 on Monday. The firm has a 50 day moving average of $112.12 and a 200-day moving average of $105.93. The firm has a market capitalization of $10.26 billion, a P/E ratio of 10.34 and a beta of 0.80. Globe Life has a 12 month low of $38.95 and a 12 month high of $132.00. The company has a current ratio of 0.05, a quick ratio of 0.05 and a debt-to-equity ratio of 0.50.

Globe Life Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, January 31st. Shareholders of record on Monday, January 6th were issued a $0.24 dividend. This represents a $0.96 annualized dividend and a yield of 0.79%. The ex-dividend date of this dividend was Monday, January 6th. Globe Life’s payout ratio is 8.12%.

Insider Activity at Globe Life

In other Globe Life news, CMO Jennifer Allison Haworth sold 9,000 shares of the company’s stock in a transaction that occurred on Monday, January 6th. The stock was sold at an average price of $112.91, for a total transaction of $1,016,190.00. Following the completion of the transaction, the chief marketing officer now owns 13,485 shares of the company’s stock, valued at $1,522,591.35. This represents a 40.03 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO Frank M. Svoboda sold 14,340 shares of Globe Life stock in a transaction on Tuesday, December 3rd. The shares were sold at an average price of $108.80, for a total transaction of $1,560,192.00. Following the completion of the sale, the chief executive officer now owns 16,396 shares in the company, valued at approximately $1,783,884.80. This trade represents a 46.66 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 39,788 shares of company stock worth $4,429,779 in the last ninety days. 1.51% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on GL. Wells Fargo & Company increased their price objective on Globe Life from $108.00 to $117.00 and gave the stock an “overweight” rating in a research report on Thursday, October 10th. Piper Sandler boosted their price objective on Globe Life from $118.00 to $130.00 and gave the stock an “overweight” rating in a report on Friday, October 25th. Jefferies Financial Group raised their target price on shares of Globe Life from $107.00 to $114.00 and gave the company a “hold” rating in a research note on Tuesday, December 10th. Evercore ISI raised shares of Globe Life from an “in-line” rating to an “outperform” rating and increased their price target for the stock from $132.00 to $143.00 in a report on Wednesday, January 8th. Finally, Raymond James lifted their price objective on shares of Globe Life from $160.00 to $188.00 and gave the stock a “strong-buy” rating in a report on Tuesday, October 15th. Five analysts have rated the stock with a hold rating, six have issued a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Globe Life presently has a consensus rating of “Moderate Buy” and an average price target of $132.18.

Globe Life Company Profile

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.